Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma
Science Advances · 2023
DOI: 10.1126/sciadv.adf7295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Sasa Vasilijic und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Neuroma, Acoustic, Hearing Loss, Deafness. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS.
Abstract (Originalsprache)
Vestibular schwannoma (VS) is an intracranial tumor arising from neoplastic Schwann cells and typically presenting with hearing loss. The traditional belief that hearing deficit is caused by physical expansion of the VS, compressing the auditory nerve, does not explain the common clinical finding that patients with small tumors can have profound hearing loss, suggesting that tumor-secreted factors could influence hearing ability in VS patients. We conducted profiling of patients’ plasma for 66 immune-related factors in patients with sporadic VS ( N > 170) and identified and validated candidate biomarkers associated with tumor size (S100B) and hearing (MCP-3). We further identified a nine-biomarker panel (TNR-R2, MIF, CD30, MCP-3, IL-2R, BLC, TWEAK, eotaxin, and S100B) with outstanding discriminatory ability for VS. These findings revealed possible therapeutic targets for VS, providing a unique diagnostic tool that may predict hearing change and tumor growth in VS patients, and may inform the timing of tumor resection to preserve hearing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA.
- Department of Otorhinolaryngology, Yokosuka Kyosai Hospital, Kanagawa, Japan.
- Harvard Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA.
- Department of Neurology, Harvard Medical School, Boston, MA, USA.
- Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Sasa Vasilijic, Hiroshi Hyakusoku, Steven Worthington, Jessica E Sagers, Mehmet I Sahin, Alyssa Brown, Takeshi Fujita, Lukas D Landegger, Richard Lewis, D Bradley Welling, Konstantina M Stankovic
Förderung
- NIDCD NIH HHS
Zitieren
APA
Vasilijic, S., Atai, N. A., Hyakusoku, H., Worthington, S., Ren, Y., Sagers, J. E., Sahin, M. I., Brown, A., Reddy, R., Malhotra, C., Fujita, T., Landegger, L. D., Lewis, R., Welling, D. B., & Stankovic, K. M. (2023). Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma. Science Advances. https://doi.org/10.1126/sciadv.adf7295
Vancouver
Vasilijic S, Atai NA, Hyakusoku H, Worthington S, Ren Y, Sagers JE, et al. Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma. Science Advances. 2023. doi:10.1126/sciadv.adf7295
BibTeX
@article{Vasilijic2023,
author = {Vasilijic, Sasa and Atai, Nadia A and Hyakusoku, Hiroshi and Worthington, Steven and Ren, Yin and Sagers, Jessica E and Sahin, Mehmet I and Brown, Alyssa and Reddy, Rohan and Malhotra, Charvi and Fujita, Takeshi and Landegger, Lukas D and Lewis, Richard and Welling, D Bradley and Stankovic, Konstantina M},
title = {Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adf7295}
}
EUVIMED